23andMe facing class action suit for making ‘genetic predictions’

Print Friendly, PDF & Email
andme
Image via Vice

It’s been a rough couple of weeks for 23andMe. First, the federal Food and Drug Administration ordered the company to immediately halt sales of its flagship $99 at-home DNA tests. Now, in the midst of that regulatory maelstrom, 23andMe is being hit with a class-action lawsuit alleging that the firm misled consumers with advertising for its personalized genome services.

At issue is the fact that 23andMe is not simply a fun way for people to play with genetics. 23andMe and other similar consumer genetics companies have moved towards marketing their services as a way to predict, and perhaps prevent, future health problems. It’s 23andMe’s claims that its interpretations of users’ genomic data can provide health benefits, and not the genetic data itself, that’s the concern.

Read the full, original story here: DNA Testing Is Not Why 23andMe Is in Trouble

Additional Resources:

 

Outbreak Featured
Infographic: Autoimmune diseases — 76 identified so far — tend to target women over men. Here is a master list

Infographic: Autoimmune diseases — 76 identified so far — tend to target women over men. Here is a master list

There are many autoimmune diseases, and taken together they affect as much as 4.5 percent of the world’s population. This ...
Are GMOs and pesticides threatening bees?

Are GMOs and pesticides threatening bees?

First introduced in 1995, neonicotinoids ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.